CASIA OpenIR

浏览/检索结果: 共4条,第1-4条 帮助

限定条件            
已选(0)清除 条数/页:   排序方式:
Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer? 期刊论文
EUROPEAN RADIOLOGY, 2018, 卷号: 28, 期号: 5, 页码: 2058-2067
作者:  Yang, Lei;  Dong, Di;  Fang, Mengjie;  Zhu, Yongbei;  Zang, Yali;  Liu, Zhenyu;  Zhang, Hongmei;  Ying, Jianming;  Zhao, Xinming;  Tian, Jie
Adobe PDF(1265Kb)  |  收藏  |  浏览/下载:300/25  |  提交时间:2018/10/10
Colorectal Neoplasms  Adenocarcinoma  Mutation  Diagnostic Imaging  Roc Curve  
A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy 期刊论文
CLINICAL CANCER RESEARCH, 2018, 卷号: 24, 期号: 15, 页码: 3583-3592
作者:  Song, Jiangdian;  Shi, Jingyun;  Dong, Di;  Fang, Mengjie;  Zhong, Wenzhao;  Wang, Kun;  Wu, Ning;  Huang, Yanqi;  Liu, Zhenyu;  Cheng, Yue;  Gan, Yuncui;  Zhou, Yongzhao;  Zhou, Ping;  Chen, Bojiang;  Liang, Changhong;  Liu, Zaiyi;  Li, Weimin;  Tian, Jie
浏览  |  Adobe PDF(1305Kb)  |  收藏  |  浏览/下载:411/91  |  提交时间:2018/10/10
EGFR-TKI therapy  
Non-invasive radiomics approach potentially predicts non-functioning pituitary adenomas subtypes before surgery 期刊论文
EUROPEAN RADIOLOGY, EUROPEAN RADIOLOGY, 2018, 2018, 卷号: 28, 28, 期号: 9, 页码: 3692-3701, 3692-3701
作者:  Zhang, Shuaitong;  Song, Guidong;  Zang, Yali;  Jia, Jian;  Wang, Chao;  Li, Chuzhong;  Tian, Jie;  Dong, Di;  Zhang, Yazhuo
浏览  |  Adobe PDF(1222Kb)  |  收藏  |  浏览/下载:359/72  |  提交时间:2018/10/10
Non-functioning Pituitary Adenomas  Null Cell Adenomas  Radiomics  Support Vector Machine  Nomograms  Non-functioning Pituitary Adenomas  Null Cell Adenomas  Radiomics  Support Vector Machine  Nomograms  
Liposomal nanohybrid cerasomes targeted to PD-L1 enable dual-modality imaging and improve antitumor treatments 期刊论文
CANCER LETTERS, 2018, 卷号: 414, 期号: 414, 页码: 230-238
作者:  Du, Yang;  Liang, Xiaolong;  Li, Yuan;  Sun, Ting;  Xue, Huadan;  Jin, Zhengyu;  Tian, Jie
浏览  |  Adobe PDF(3002Kb)  |  收藏  |  浏览/下载:563/232  |  提交时间:2018/01/03
Programmed Cell Death Ligand-1  Near Infrared Fluorescence  Magnetic Resonance Imaging  Paclitaxel  Chemotherapy  Immunotherapy